Program & Accreditation Details
This enduring activity provides a comprehensive overview of glucocorticoid therapy in rheumatologic disease, including mechanisms of action, clinical indications, dosing strategies, and risk mitigation. Emphasis is placed on balancing therapeutic benefit with potential adverse effects and supporting safe, evidence-based use in clinical practice.
Upon completion of this activity, learners will better be able to:
- Describe the pharmacologic mechanisms and clinical effects of glucocorticoids.
- Identify dose-dependent risks associated with glucocorticoid therapy and appropriate monitoring strategies.
- Apply evidence-based approaches to glucocorticoid use in rheumatologic disease management, including appropriate dosing and administration
The target audience for this forum includes registered nurses (RNs), nurse practitioners (NPs), licensed practical and vocational nurses (LPNs/LVNs), and other healthcare professionals who are engaged in clinical practice, education, research, and advocacy for the care of adult and pediatric patients with rheumatic diseases.
The content of this education will also be applicable to healthcare professionals new to rheumatology, as well as students considering entering the field of rheumatology.
J. Nicholas Manwaring, MSN, APRN, FNP-CCDR USPHS
FacultyIndian Health Service
Alaska Native Tribal Health Consortium
Internal Medicine, Division of Rheumatology
Anchorage, Alaska
Carolyn Zic, MSN, FNP-C
Accredited Provider Program Director
The Rheumatology Nurses Society is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation (Provider No. P0500).
Participants who view the activity in its entirety, complete the post-test with a minimum passing score of 75%, and complete the evaluation will be awarded 1.0 ANCC Contact Hour.
In compliance with ANCC standards for integrity and independence in nursing continuing professional development, all individuals in a position to control content have disclosed all financial relationships with ineligible companies within the past 24 months.
No relevant financial relationships were identified for any individuals in a position to control content.
No commercial support was received for this activity.
This course will expire on May 1, 2027.
